We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
17.00 | 1.06% | 1,615.00 | 1,614.00 | 1,615.00 | 1,626.00 | 1,588.00 | 1,595.00 | 18,355,498 | 16:35:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.49 | 66.47B |
TIDMGSK
RNS Number : 8651N
GlaxoSmithKline PLC
11 May 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ============================================================== a) Name Ms E Walmsley === ====================== ====================================== b) Position/status Chief Executive Officer === ====================== ====================================== c) Initial notification/ Initial notification amendment === ====================== ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================== a) Name GlaxoSmithKline plc === ====================== ====================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================== a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ====================================== b) Nature of Acquisition of Ordinary Shares the transaction under the Company's Share Reward Plan. === ====================== ====================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ----------------------- GBP14.6664 9 (partnership shares) ----------- ----------------------- GBP14.6664 9 (matching shares) ----------- ----------------------- === ====================== ====================================== d) Aggregated information Aggregated volume Price 18 Ordinary Shares GBP14.6664 === ====================== ====================================== e) Date of the 2018-05-10 transaction === ====================== ====================================== f) Place of the London Stock Exchange (XLON) transaction === ====================== ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ============================================================== a) Name Mr R G Connor === ====================== ====================================== b) Position/status President, Global Manufacturing & Supply === ====================== ====================================== c) Initial notification/ Initial notification amendment === ====================== ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================== a) Name GlaxoSmithKline plc === ====================== ====================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================== a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ====================================== b) Nature of Acquisition of Ordinary Shares the transaction under the Company's Share Reward Plan. === ====================== ====================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ----------------------- GBP14.6664 9 (partnership shares) ----------- ----------------------- GBP14.6664 9 (matching shares) ----------- ----------------------- === ====================== ====================================== d) Aggregated information Aggregated volume Price 18 Ordinary Shares GBP14.6664 === ====================== ====================================== e) Date of the 2018-05-10 transaction === ====================== ====================================== f) Place of the London Stock Exchange (XLON) transaction === ====================== ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ============================================================== a) Name Mr S Dingemans === ====================== ====================================== b) Position/status Chief Financial Officer === ====================== ====================================== c) Initial notification/ Initial notification amendment === ====================== ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================== a) Name GlaxoSmithKline plc === ====================== ====================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================== a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ====================================== b) Nature of Acquisition of Ordinary Shares the transaction under the Company's Share Reward Plan. === ====================== ====================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ----------------------- GBP14.6664 9 (partnership shares) ----------- ----------------------- GBP14.6664 9 (matching shares) ----------- ----------------------- === ====================== ====================================== d) Aggregated information Aggregated volume Price 18 Ordinary Shares GBP14.6664 === ====================== ====================================== e) Date of the 2018-05-10 transaction === ====================== ====================================== f) Place of the London Stock Exchange (XLON) transaction === ====================== ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ============================================================== a) Name Mr N Hirons === ====================== ====================================== b) Position/status SVP, Global Ethics & Compliance === ====================== ====================================== c) Initial notification/ Initial notification amendment === ====================== ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================== a) Name GlaxoSmithKline plc === ====================== ====================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================== a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ====================================== b) Nature of Acquisition of Ordinary Shares the transaction under the Company's Share Reward Plan. === ====================== ====================================== c) Price(s) and Price(s) Volume(s)
volume(s) ----------- ----------------------- GBP14.6664 9 (partnership shares) ----------- ----------------------- GBP14.6664 9 (matching shares) ----------- ----------------------- === ====================== ====================================== d) Aggregated information Aggregated volume Price 18 Ordinary Shares GBP14.6664 === ====================== ====================================== e) Date of the 2018-05-10 transaction === ====================== ====================================== f) Place of the London Stock Exchange (XLON) transaction === ====================== ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ============================================================== a) Name Mr L Miels === ====================== ====================================== b) Position/status President, Global Pharmaceuticals === ====================== ====================================== c) Initial notification/ Initial notification amendment === ====================== ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================== a) Name GlaxoSmithKline plc === ====================== ====================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================== a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ====================================== b) Nature of Acquisition of Ordinary Shares the transaction under the Company's Share Reward Plan. === ====================== ====================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ----------------------- GBP14.6664 9 (partnership shares) ----------- ----------------------- GBP14.6664 9 (matching shares) ----------- ----------------------- === ====================== ====================================== d) Aggregated information Aggregated volume Price 18 Ordinary Shares GBP14.6664 === ====================== ====================================== e) Date of the 2018-05-10 transaction === ====================== ====================================== f) Place of the London Stock Exchange (XLON) transaction === ====================== ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ============================================================== a) Name Mr D S Redfern === ====================== ====================================== b) Position/status Chief Strategy Officer === ====================== ====================================== c) Initial notification/ Initial notification amendment === ====================== ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================== a) Name GlaxoSmithKline plc === ====================== ====================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================== a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ====================================== b) Nature of Acquisition of Ordinary Shares the transaction under the Company's Share Reward Plan. === ====================== ====================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ----------------------- GBP14.6664 9 (partnership shares) ----------- ----------------------- GBP14.6664 9 (matching shares) ----------- ----------------------- === ====================== ====================================== d) Aggregated information Aggregated volume Price 18 Ordinary Shares GBP14.6664 === ====================== ====================================== e) Date of the 2018-05-10 transaction === ====================== ====================================== f) Place of the London Stock Exchange (XLON) transaction === ====================== ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ============================================================== a) Name Ms C Thomas === ====================== ====================================== b) Position/status SVP, Human Resources === ====================== ====================================== c) Initial notification/ Initial notification amendment === ====================== ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================== a) Name GlaxoSmithKline plc === ====================== ====================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================== a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ====================================== b) Nature of Acquisition of Ordinary Shares the transaction under the Company's Share Reward Plan. === ====================== ====================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ----------------------- GBP14.6664 9 (partnership shares) ----------- ----------------------- GBP14.6664 9 (matching shares) ----------- ----------------------- === ====================== ====================================== d) Aggregated information Aggregated volume Price 18 Ordinary Shares GBP14.6664 === ====================== ====================================== e) Date of the 2018-05-10 transaction === ====================== ====================================== f) Place of the London Stock Exchange (XLON) transaction === ====================== ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ============================================================== a) Name Mr P C Thomson === ====================== ====================================== b) Position/status President, Global Affairs === ====================== ====================================== c) Initial notification/ Initial notification amendment === ====================== ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================== a) Name GlaxoSmithKline plc === ====================== ====================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================== a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ====================================== b) Nature of Acquisition of Ordinary Shares the transaction under the Company's Share Reward Plan. === ====================== ====================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ----------------------- GBP14.6664 8 (partnership shares) ----------- ----------------------- GBP14.6664 8 (matching shares) ----------- ----------------------- === ====================== ====================================== d) Aggregated information Aggregated volume Price 16 Ordinary Shares GBP14.6664 === ====================== ====================================== e) Date of the 2018-05-10 transaction === ====================== ====================================== f) Place of the London Stock Exchange (XLON) transaction === ====================== ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ============================================================== a) Name Mrs V A Whyte === ====================== ====================================== b) Position/status Company Secretary === ====================== ====================================== c) Initial notification/ Initial notification amendment === ====================== ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================== a) Name GlaxoSmithKline plc === ====================== ====================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================== a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ====================================== b) Nature of Acquisition of Ordinary Shares the transaction under the Company's Share Reward Plan. === ====================== ====================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ----------------------- GBP14.6664 9 (partnership shares) ----------- ----------------------- GBP14.6664 9 (matching shares) ----------- ----------------------- === ====================== ====================================== d) Aggregated information Aggregated volume Price 18 Ordinary Shares GBP14.6664 === ====================== ====================================== e) Date of the 2018-05-10 transaction === ====================== ====================================== f) Place of the London Stock Exchange (XLON) transaction === ====================== ======================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHZFLFFVEFFBBX
(END) Dow Jones Newswires
May 11, 2018 10:17 ET (14:17 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions